Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
New Haven, CT 06510Phone+1 203-785-2360Fax+1 203-785-4116
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Johns Hopkins UniversityResidency, Internal Medicine, 2009 - 2012
Topiwala National Medical CollegeClass of 2007
Certifications & Licensure
CT State Medical License 2015 - 2025
PA State Medical License 2010 - 2015- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck Start of enrollment: 2017 Mar 24
- Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer Start of enrollment: 2019 Aug 16
Roles: Principal Investigator
Publications & Presentations
PubMed
- 11 citationsClinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy.G. Loganadane, Benjamin H. Kann, Henry Park, Skyler B. Johnson, Saral Mehra
Anticancer Research. 2019-09-01 - 53 citationsTreating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.Aarti Bhatia, Barbara Burtness
Drugs. 2023-02-01 - 95 citationsHuman Papillomavirus–Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical TrialsAarti K. Bhatia, Barbara Burtness
Journal of Clinical Oncology. 2015-09-08
Journal Articles
- Adjuvant Chemotherapy Is Associated with Improved Survival for Late‐Stage Salivary Squamous Cell CarcinomaHenry S Park, Shayan Cheraghlou, Benjamin L Judson, Aarti Bhatia, Saral Mehra, Amy Schettino, Wendell G Yarbrough, Michael D Otremba, The Laryngoscope
Press Mentions
Emerging Therapies Show Promise in Head and Neck CancerMay 4th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
